This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Jan;118(1):223-4.

doi: 10.1016/j.ophtha.2010.07.031.

Rituximab for uveitis

Elisabetta Miserocchi, Irene Pontikaki, Giulio Modorati, Francesco Bandello, Pier Luigi Meroni, Valeria Gerloni

PMID: 21199719
DOI: 10.1016/j.ophtha.2010.07.031

Rituximab for uveitis

Elisabetta Miserocchi et al. Ophthalmology. 2011 Jan.

. 2011 Jan;118(1):223-4.

doi: 10.1016/j.ophtha.2010.07.031.

Authors

Elisabetta Miserocchi, Irene Pontikaki, Giulio Modorati, Francesco Bandello, Pier Luigi Meroni, Valeria Gerloni

PMID: 21199719
DOI: 10.1016/j.ophtha.2010.07.031

No abstract available

PubMed Disclaimer

Similar articles

Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.
Miserocchi E, Pontikaki I, Modorati G, Gattinara M, Meroni PL, Gerloni V. Miserocchi E, et al. Autoimmun Rev. 2011 Nov;11(1):35-9. doi: 10.1016/j.autrev.2011.07.001. Epub 2011 Jul 13. Autoimmun Rev. 2011. PMID: 21763790 Review.
Antibodies against CD20 (rituximab) for treating multiple sclerosis: US20100233121.
Taupin P. Taupin P. Expert Opin Ther Pat. 2011 Jan;21(1):111-4. doi: 10.1517/13543776.2011.530253. Epub 2010 Dec 15. Expert Opin Ther Pat. 2011. PMID: 21155688
Rapid and complete resolution of lichen planopilaris in juvenile chronic arthritis treated with rituximab.
Erras S, Mouna Z, Akhdari N, Belaabidia B, Essaadouni L. Erras S, et al. Eur J Dermatol. 2011 Jan-Feb;21(1):116-7. doi: 10.1684/ejd.2010.1176. Eur J Dermatol. 2011. PMID: 21300607 No abstract available.
Successful treatment of recurrent focal segmental glomerulosclerosis after renal transplantation by lymphocytapheresis and rituximab.
Shimizu M, Kitagawa K, Nishio S, Yokoyama T, Furuichi K, Ohta K, Wada T, Yachie A. Shimizu M, et al. Transpl Int. 2010 Sep;23(9):e53-5. doi: 10.1111/j.1432-2277.2010.01118.x. Epub 2010 Jun 2. Transpl Int. 2010. PMID: 20536913 No abstract available.
Rituximab for noninfectious uveitis.
Miserocchi E, Modorati G. Miserocchi E, et al. Dev Ophthalmol. 2012;51:98-109. doi: 10.1159/000336188. Epub 2012 Apr 17. Dev Ophthalmol. 2012. PMID: 22517208 Review.

See all similar articles

Cited by

Pediatric uveitis: An update.
Majumder PD, Biswas J. Majumder PD, et al. Oman J Ophthalmol. 2013 Sep;6(3):140-50. doi: 10.4103/0974-620X.122267. Oman J Ophthalmol. 2013. PMID: 24379547 Free PMC article. Review.
Pharmacotherapy for uveitis: current management and emerging therapy.
Barry RJ, Nguyen QD, Lee RW, Murray PI, Denniston AK. Barry RJ, et al. Clin Ophthalmol. 2014 Sep 22;8:1891-911. doi: 10.2147/OPTH.S47778. eCollection 2014. Clin Ophthalmol. 2014. PMID: 25284976 Free PMC article. Review.
Recent advances in the treatment of juvenile idiopathic arthritis-associated uveitis.
Chen JL, Abiri P, Tsui E. Chen JL, et al. Ther Adv Ophthalmol. 2021 Feb 18;13:2515841420984572. doi: 10.1177/2515841420984572. eCollection 2021 Jan-Dec. Ther Adv Ophthalmol. 2021. PMID: 33681703 Free PMC article. Review.
Rituximab in refractory Vogt-Koyanagi-Harada disease.
Dolz-Marco R, Gallego-Pinazo R, Díaz-Llopis M. Dolz-Marco R, et al. J Ophthalmic Inflamm Infect. 2011 Dec;1(4):177-80. doi: 10.1007/s12348-011-0027-9. Epub 2011 Jul 9. J Ophthalmic Inflamm Infect. 2011. PMID: 21744181 Free PMC article.
Causal role of immune cells in uveitis: Mendelian randomization study.
Wu J, Fang C, Zhou Y, Wang M, Li Q, Dong S. Wu J, et al. Front Immunol. 2024 Jul 9;15:1402074. doi: 10.3389/fimmu.2024.1402074. eCollection 2024. Front Immunol. 2024. PMID: 39044820 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information